Advances in targeting histone deacetylase for treatment of solid tumors

Abstract Histone deacetylase (HDAC) serves as a critical molecular regulator in the pathobiology of various malignancies and have garnered attention as a viable target for therapeutic intervention. A variety of HDAC inhibitors (HDACis) have been developed to target HDACs. Many preclinical studies ha...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Mu-Qi Shi, Ying Xu, Xin Fu, De-Si Pan, Xian-Ping Lu, Yi Xiao, Yi-Zhou Jiang
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	BMC 2024-05-01
Serie:	Journal of Hematology & Oncology
Ämnen:	Histone deacetylase Histone deacetylase inhibitor Solid tumor Combination therapy Clinical administration
Länkar:	https://doi.org/10.1186/s13045-024-01551-8
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!